123 related articles for article (PubMed ID: 7521616)
1. Use of high dose rate gammamed brachytherapy in the palliative treatment of gynaecological cancer.
Tan HS
Ann Acad Med Singap; 1994 Mar; 23(2):231-4. PubMed ID: 7521616
[TBL] [Abstract][Full Text] [Related]
2. High dose rate brachytherapy for the palliation of malignant dysphagia.
Homs MY; Eijkenboom WM; Coen VL; Haringsma J; van Blankenstein M; Kuipers EJ; Siersema PD
Radiother Oncol; 2003 Mar; 66(3):327-32. PubMed ID: 12742273
[TBL] [Abstract][Full Text] [Related]
3. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A
Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550
[TBL] [Abstract][Full Text] [Related]
4. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
[TBL] [Abstract][Full Text] [Related]
5. [High-dose endobronchial brachytherapy in malignant tumors of the lung].
Escobar Sacristán J; de Granda Orive JI; Gutiérrez Jiménez T; Martínez Albiach JM; Fuentes Ramos M; Herrera de la Rosa A
Arch Bronconeumol; 1997 Jun; 33(6):278-83. PubMed ID: 9289322
[TBL] [Abstract][Full Text] [Related]
6. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
7. High dose rate intraluminal brachytherapy in the treatment of malignant airway obstructions.
Petera J; Spásová I; Neumanová R; Skricková J; Salajka F; Hrazdírová A; Kaplanová J; Coupková H; Coupek P; Kucera M
Neoplasma; 2001; 48(2):148-53. PubMed ID: 11478697
[TBL] [Abstract][Full Text] [Related]
8. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
9. Intraluminal brachytherapy in the treatment of oesophageal cancers--some preliminary results.
Wee JT; Theobald DR; Chua EJ
Ann Acad Med Singap; 1994 Mar; 23(2):226-30. PubMed ID: 7521615
[TBL] [Abstract][Full Text] [Related]
10. High dose rate intraluminal brachytherapy in combination with external beam radiotherapy for palliative treatment of cancer rectum.
Begum N; Asghar AH; N S; Khan SM; Khan A
J Coll Physicians Surg Pak; 2003 Nov; 13(11):633-6. PubMed ID: 14700489
[TBL] [Abstract][Full Text] [Related]
11. High dose rate brachytherapy for superficial cancer of the esophagus.
Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
[TBL] [Abstract][Full Text] [Related]
12. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
13. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Corner C; Bryant L; Chapman C; Glynne-Jones R; Hoskin PJ
Brachytherapy; 2010; 9(1):66-70. PubMed ID: 19846349
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R
Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547
[TBL] [Abstract][Full Text] [Related]
16. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
[TBL] [Abstract][Full Text] [Related]
17. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
18. [Reappraisal of the role of endobronchial brachytherapy in the management of lung cancer: ten years' experience at the centre Antoine-Lacassagne].
Magné N; Porsin B; Marcy PY; Benezery K; Poudenx M; Vallino P; Otto J; Marcié S; Lagrange JL
Cancer Radiother; 2003 Jun; 7(3):160-5. PubMed ID: 12834770
[TBL] [Abstract][Full Text] [Related]
19. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
[TBL] [Abstract][Full Text] [Related]
20. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]